The Company was incorporated and registered in England and Wales on 13 February 2013 as a private limited company and re-registered on 25 November 2014 as a public limited company. The Company's wholly owned US operating subsidiary, Hemogenyx LLC, is incorporated in the state of Delaware.

Registered Office

5 Fleet Place
London
EC4M 7RD

Company registered in England & Wales, No. 08401609

Prospectus

The Prospectus for HemoGenyx upon admission to the LSE on 5th October 2017 is available in PDF format to download here.

Documents re. the acquisition of Hemogenyx Pharmaceuticals plc by Silver Falcon Plc

PKF Consent Letter

Aruwon Consent Letter

Peterhouse Consent Letter

Aruwon Expert Report

Electronic Transmission Disclaimer

Strictly Not To Be Forwarded To Any Other Persons

IMPORTANT: You must read the following disclaimer before continuing. This electronic transmission applies to the attached document and you are therefore advised to read this disclaimer carefully before reading, accessing or making any other use of the attached prospectus (the “Document”) relating to Silver Falcon plc (the “Company”) dated 8 September 2017 accessed from this page or otherwise received as a result of such access and you are therefore advised to read this disclaimer before reading, accessing or making any other use of the attached document.

In accessing the attached Document, you agree to be bound by the following terms and conditions, including any modifications to them from time to time, each time you receive any information from us a result of such access. You acknowledge that this electronic transmission and the delivery of the attached document is confidential and intended for you only and you agree you will not forward, reproduce or publish this electronic transmission or the attached document to any other person. The Document has been prepared solely in connection with the proposed acquisition of Hemogenyx Pharmaceuticals plc, a Placing and Subscription of shares of the Company and readmission of the entire issued share capital of the Company to trading on the Main Market of the London Stock Exchange plc, with a standard listing.

The attached Document may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. The Document does not constitute an offer to sell, or a solicitation of any offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “US Securities Act”) or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US person (as defined under regulation S under the US Securities Act). The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.

Neither the Document nor any copy of it may be taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom, Canada, Australia, Japan or the Republic of South Africa or to any resident thereof, or any other jurisdiction where such action would breach any relevant legislation. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of the Document in other jurisdictions may be restricted by law and the persons into whose possession the Document comes should inform themselves about, and observe, any such restrictions.

Confirmation of your representation: This electronic transmission and the attached document is delivered to you on the basis that you are deemed to have represented to the Company that (i) you are outside of the United States and are not a US person, (ii) you are not located in Canada, Australia, Japan or the Republic of South Africa, (iii) if you are in the UK you are a person who is lawfully able to access the Document, and (iv) you consent to delivery by electronic transmission.

You are reminded that you have received this electronic transmission and the attached Document on the basis that you are a person into whose possession this document may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not nor are you authorised to deliver the Document, electronically or otherwise, to any other person. The Document has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently neither the Company, nor any of its affiliates accepts any liability or responsibility whatsoever in respect of any difference between the document distributed to you in electronic format and the hard copy version. By accessing the attached Document, you consent to receiving it in electronic form.

Continue to Prospectus

Cancel